CARAMORI, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 21.921
AS - Asia 12.328
EU - Europa 7.314
SA - Sud America 2.152
Continente sconosciuto - Info sul continente non disponibili 319
AF - Africa 256
OC - Oceania 46
Totale 44.336
Nazione #
US - Stati Uniti d'America 21.429
SG - Singapore 4.431
CN - Cina 3.139
IT - Italia 1.854
BR - Brasile 1.661
UA - Ucraina 1.517
VN - Vietnam 1.390
DE - Germania 1.132
HK - Hong Kong 1.113
TR - Turchia 849
GB - Regno Unito 652
FI - Finlandia 581
FR - Francia 438
RU - Federazione Russa 325
JP - Giappone 305
BD - Bangladesh 267
SE - Svezia 266
IN - India 208
MX - Messico 207
PL - Polonia 195
CA - Canada 193
AR - Argentina 179
ID - Indonesia 128
IQ - Iraq 95
ZA - Sudafrica 90
NL - Olanda 78
EC - Ecuador 71
CO - Colombia 67
PK - Pakistan 58
PY - Paraguay 44
AU - Australia 40
ES - Italia 40
MY - Malesia 39
PH - Filippine 39
VE - Venezuela 39
CL - Cile 37
MA - Marocco 37
UZ - Uzbekistan 33
AE - Emirati Arabi Uniti 32
SA - Arabia Saudita 32
BE - Belgio 31
LT - Lituania 31
EG - Egitto 26
KE - Kenya 26
TN - Tunisia 26
CR - Costa Rica 22
PE - Perù 22
UY - Uruguay 20
AT - Austria 19
KZ - Kazakistan 19
CH - Svizzera 18
CZ - Repubblica Ceca 18
IE - Irlanda 18
JM - Giamaica 18
NP - Nepal 18
KR - Corea 17
RO - Romania 16
BG - Bulgaria 15
TW - Taiwan 13
AL - Albania 12
IL - Israele 11
DZ - Algeria 10
JO - Giordania 10
LB - Libano 10
BO - Bolivia 9
ET - Etiopia 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
HU - Ungheria 8
IR - Iran 8
OM - Oman 8
SV - El Salvador 8
BY - Bielorussia 7
EU - Europa 7
PT - Portogallo 7
BH - Bahrain 6
HN - Honduras 6
HR - Croazia 6
SY - Repubblica araba siriana 6
DO - Repubblica Dominicana 5
GR - Grecia 5
GT - Guatemala 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
CI - Costa d'Avorio 4
MN - Mongolia 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
AO - Angola 3
BB - Barbados 3
CG - Congo 3
KG - Kirghizistan 3
KH - Cambogia 3
MM - Myanmar 3
MU - Mauritius 3
NO - Norvegia 3
PR - Porto Rico 3
Totale 43.970
Città #
Singapore 2.750
Fairfield 2.049
Ashburn 1.961
Woodbridge 1.897
Jacksonville 1.595
Houston 1.230
San Jose 1.230
Chandler 1.143
Hong Kong 1.104
Santa Clara 930
Ann Arbor 861
Wilmington 765
Beijing 747
Seattle 724
Cambridge 590
Izmir 534
Nanjing 527
Ho Chi Minh City 462
Council Bluffs 378
Princeton 331
Munich 318
Hanoi 311
New York 301
Tokyo 290
Los Angeles 269
Milan 259
Lauterbourg 257
Helsinki 235
Washington 217
Dallas 206
Warsaw 186
San Diego 179
Ferrara 153
Mexico City 146
Boardman 145
Shenyang 144
São Paulo 133
Nanchang 132
Rome 107
Hebei 101
Changsha 93
Tianjin 90
Jiaxing 87
Addison 86
Chicago 84
Hefei 84
Shanghai 84
Toronto 77
Dearborn 69
Orem 64
London 61
Da Nang 60
Haiphong 59
Jinan 59
Moscow 58
Buffalo 57
Rio de Janeiro 54
Naples 53
Brooklyn 51
Chennai 50
Verona 50
Jakarta 49
Norwalk 46
Kunming 45
Frankfurt am Main 42
Guangzhou 40
Zhengzhou 40
Atlanta 39
Redwood City 38
Ningbo 37
Turku 37
Baghdad 36
Falls Church 36
Mountain View 36
The Dalles 36
Johannesburg 35
Belo Horizonte 34
Boston 34
Montreal 34
Hải Dương 33
Bologna 32
Curitiba 30
Denver 29
Taizhou 29
Campinas 27
Florence 27
Phoenix 27
Brussels 26
Mumbai 26
San Francisco 26
Bremen 25
Kuala Lumpur 25
Quito 25
Amsterdam 24
Orange 24
Poplar 24
Tashkent 24
Turin 24
Biên Hòa 23
Bogotá 23
Totale 28.574
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 532
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 457
Expiratory flow limitation as a risk factor for pulmonary complications after major abdominal surgery 382
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 348
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 348
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 330
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 317
Targeting Th2 cells in asthmatic airways 305
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 289
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 270
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 266
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 251
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 238
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 236
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 232
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 222
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 221
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 219
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 217
Activation of NF-kappaB transcription factor in asthma death 216
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 216
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 215
Malattie polmonari primitive da cause dismetaboliche. 214
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 214
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 212
Cellule staminali e patologia polmonare dell’adulto 211
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 210
Sindrome epatopolmonare. 208
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 208
Airway obstruction in chronic obstructive pulmonary disease. 206
A link between lung injury and inflammatory myopathies: making the diagnosis 205
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 205
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes 203
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 202
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 199
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 198
Definizione e classificazione delle broncopneumopatie croniche ostruttive. 195
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 194
Ectopic thymoma simulating a pericardial cyst: case report 194
Models of infection and exacerbations in COPD. 191
COPD exacerbations: definitions and classifications 190
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 189
Definition, clinical features, investigations and differential diagnosis in asthma. 188
Birbeck granules: contribution to the comprehnsion of intracytoplasmic evolution 188
Corticosteroidi, disodiocromoglicato e nedocromile nella terapia dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 186
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 186
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 184
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 183
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 182
Extrapulmonary tuberculosis 182
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 181
Asthma: A Chronic Infectious Disease? 178
Convergent sets of data from In Vivo and In Vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis 178
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 178
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 177
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression 177
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study 177
STAT6 expression in T cells, alveolar macrophages and bronchial biopsies of normal and asthmatic subjects 176
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 176
Allergen responses modified by a GATA3 DNAzyme 175
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 173
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 172
Mechanisms involved in lung cancer development in COPD 172
Molecular mechanisms of respiratory virus-induced inflammation. 171
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 171
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 171
Anti-inflammatory treatments for asthma: Past, present, future 170
Steroid-sparing Strategies: Other Combinations 169
Malattie della pleura 169
Clinical definition of COPD exacerbations and classification of their severity 169
Interactions of airway pathogens and inflammatory processes 169
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview 168
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 168
Transcription Factors: Overview 168
Near-fatal asthma phenotype in the ENFUMOSA cohort 167
Chronic obstructive pulmonary disease international guidelines 167
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 166
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 164
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 163
Pathophysiology of viral-induced exacerbations of COPD 163
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 163
The level of control of mild asthma in general practice: An observational community-based study 161
Anatomia e fisiologia clinica della pleura. 161
Asma e leucotrieni 160
Therapies acting on transcription: overview. 160
New insights into the molecular mechanisms of corticosteroids actions 159
Interactions of airway pathogens and inflammatory processes 159
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation 158
STAT2 activation in smokers and patients with chronic obstructive pulmonary disease 158
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 158
Chronic Obstructive pulmonary disease and lung cancer: New molecular insights 157
Respiratory mechanics at different PEEP level during Anaesthesia in elderly: a pilot study. 157
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 156
Gender and respiratory infections. 155
COPD immunopathology 154
COPD pathology in the small airways 153
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 152
New drugs targeting Th2 lymphocytes in asthma 151
Novel anti-inflammatory treatments for asthma and COPD 150
Totale 20.203
Categoria #
all - tutte 201.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 32.048
Totale 233.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.506 0 286 199 218 74 94 99 163 93 235 265 780
2022/20232.619 350 61 78 324 375 457 69 244 360 25 183 93
2023/20241.103 148 171 53 30 86 139 27 47 23 37 42 300
2024/20255.145 186 114 429 135 636 401 192 414 848 734 587 469
2025/202615.599 1.218 906 1.451 2.132 2.080 962 1.552 1.108 1.478 1.781 579 352
2026/2027965 508 457 0 0 0 0 0 0 0 0 0 0
Totale 44.336